open access

Ahead of print
Pictures in Oncology
Published online: 2022-05-25
Get Citation

Prolonged QTc interval as a side effect of concomitant administration of CDK4/6 inhibitor and cytochrome P-450 enzyme inhibitors

Aleksandra Grela-Wojewoda1, Mirosława Puskulluoglu1, Joanna Lompart1, Marek Ziobro1, Ewa Konduracka2
DOI: 10.5603/NJO.a2022.0032
Affiliations
  1. Department of Clinical Oncology, The Maria Skłodowska-Curie National Research Institute of Oncology, Krakow Branch, Krakow, Poland
  2. Department of Coronary Disease and Heart Failure, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland

open access

Ahead of print
Pictures in oncology
Published online: 2022-05-25

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Prolonged QTc interval as a side effect of concomitant administration of CDK4/6 inhibitor and cytochrome P-450 enzyme inhibitors

Journal

Nowotwory. Journal of Oncology

Issue

Ahead of print

Article type

Pictures in Oncology

Published online

2022-05-25

Page views

13

Article views/downloads

17

DOI

10.5603/NJO.a2022.0032

Authors

Aleksandra Grela-Wojewoda
Mirosława Puskulluoglu
Joanna Lompart
Marek Ziobro
Ewa Konduracka

References (2)
  1. Grela-Wojewoda A, Pacholczak-Madej R, Adamczyk A, et al. Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer. Int J Mol Sci. 2022; 23(5): 2815.
  2. Rascon K, Flajc G, De Angelis C, et al. Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients. Ann Pharmacother. 2019; 53(5): 501–509.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl